Key Highlights

● Exelon closed at $43.50 on October 16, trading below the analyst target.

● The consensus 12-month price target is $48.53, implying about 11.6% upside.

● Analysts are split 5 Buy, 14 Hold, and 2 Sell on the stock.

● Targets range from $41 to $58 across 21 analysts.

Exelon Corporation (NASDAQ:EXC) closed at $43.50 on October 16, 2026, according to market data. The stock is a constituent of the Nasdaq-100 and trades on the Nasdaq. The consensus analyst price target is $48.53, which is 11.6% above the latest close, implying 11.6% upside. The shares are drawing attention this week because of fresh analyst activity and upcoming earnings: the next results are expected on October 30, 2026 (Q3 2026; call at 10:00 a.m. ET).

What Is the Latest Analyst Price Target?

The mean consensus target is $48.53 across 21 analysts, with a median of $48.00. Individual forecasts range from a low of $41.00 to a high of $58.00. Measured against the 16 October close of $43.50, the consensus target suggests 11.6% upside. The analyst data on the source page was last updated on September 22, 2026, nearly a month before the price date, so the consensus may be out of date and should be treated with caution. These figures are forecasts, not guarantees, and different data providers can show slightly different consensus numbers because of timing and methodology.

What Are Analysts Saying?

The overall consensus rating is Hold, with the ratings split as 5 Buy (4 Strong Buy, 1 Buy), 14 Hold, 2 Sell (Strong Sell). Recent broker actions include the following. Argus Research (22 Sep) reiterated Buy and lowered its target to $49 from $52; Morgan Stanley (21 Sep) reiterated Hold with a $50 target, down from $53; Bank of America Securities (15 Sep) maintained Hold at $50; J.P. Morgan (25 Aug) maintained Hold with a $47 target; and Truist (18 Aug) maintained Hold at $48. Separately, KeyBanc was reported to have upgraded the shares to Sector Weight from Underweight around 12 October, citing valuation.

Recent target revisions have mostly been downward, and the majority of covering analysts rate the shares Hold.

What Could Help the Stock Reach the Price Target?

If the consensus proves accurate, the shares would need to close the gap to $48.53. Several factors could support that outcome. Company developments are one: Exelon has scheduled its Q3 2026 results for October 30, 2026. In late August it announced that its chief operating officer, Mike Innocenzo, would leave the company in 2027, and on 14 October it was named for a corporate award by the Executive Leadership Council.

Beyond this, results that meet or exceed expectations, firm guidance and stable sector conditions would typically support analyst estimates and could encourage further target upgrades. Equally, a broadly supportive market backdrop can narrow the gap between price and targets. None of these outcomes is assured.

What Could Prevent the Stock Reaching the Target?

Analyst targets are opinions about a twelve-month horizon and are frequently revised. Earnings that fall short of expectations, weaker guidance, changes in interest rates, regulatory or policy shifts and wider market volatility could all cause the shares to underperform the consensus. The spread between the lowest target ($41.00) and highest target ($58.00) shows that professional forecasters do not agree on fair value. Investors should also note that consensus figures can lag recent events, so the numbers cited here may already have been overtaken by newer broker notes.

What Should Investors Watch Next?

The key event is the next earnings report, expected on October 30, 2026 (Q3 2026; call at 10:00 a.m. ET). Investors may wish to watch management commentary and guidance, any changes to broker ratings and targets following the results, and the direction of the consensus mean and median in the weeks ahead. Any further company announcements, such as acquisitions, dividends or leadership changes, may also influence sentiment.

A Gap That Needs Proof

On the verified figures, Exelon Corporation (EXC) closed at $43.50 on October 16, 2026, while the analyst consensus target of $48.53 suggests 11.6% upside, with a Hold consensus rating across 21 analysts.